Amphastar Pharmaceuticals, Inc.

AMPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Feb 26, 2026 10-K
8-K Feb 26, 2026 8-K
8-K Jan 12, 2026 8-K
4 Dec 18, 2025
4 Dec 15, 2025
144 Dec 11, 2025
144 Dec 10, 2025
144 Nov 28, 2025
4 Nov 25, 2025
144 Nov 25, 2025
4 Nov 17, 2025
144 Nov 13, 2025
10-Q Nov 6, 2025 10-Q
8-K Nov 6, 2025 8-K
4 Nov 5, 2025
144 Nov 3, 2025
8-K Oct 24, 2025 1.01
SCHEDULE 13G/A Oct 17, 2025
4 Oct 2, 2025
144 Oct 1, 2025
8-K Sep 18, 2025 8-K
4 Sep 3, 2025
144 Sep 2, 2025
8-K Aug 12, 2025 8-K
10-Q Aug 7, 2025 10-Q
← Newer Page 3 of 39 · 954 filings Older →